Cancer Chemotherapy
ADVERSE DRUG REACTIONS TO CANCER CHEMOTHERAPY IN A REGIONAL CANCER CENTER IN NORTHEAST INDIA
... to cancer chemotherapy are nausea and vomiting, alopecia, myelosuppression, haemorrhagic cystitis, mucositis , increased toxicity with impaired renal function, cardiac toxicity, hot flushes, electrolyte ...
6
Genotyping panel for assessing response to cancer chemotherapy
... lished and systemically validated by Applied Biosystems to have high precision [18,19]. The method can detect 48 SNPs in one single well for each patient sample, adapted here to a 96-well plate format covering more than ...
18
Pharmacogenomics of Cancer Chemotherapy
... recently chemotherapy of cancer was usually determined by the pathology of the tumor, ...colon cancer contains a fluoropyrimidine, such as 5- fluorouracil (5FU) or a prodrug such as capecitabine or ...
6
Chapter 55. Cancer Chemotherapy Katzung PHARMACOLOGY, 9e > Section VIII. Chemotherapeutic Drugs > Chapter 55. Cancer Chemotherapy >
... disseminated cancer, chemotherapy provides palliative rather than curative therapy at ...of cancer and enhancement in the overall quality of ...in cancer chemotherapy have also begun to ...
48
Cancer chemotherapy: targeting folic acid synthesis
... lung cancer, second-line treatment of NSCLC, and first-line treatment of malignant pleural meso- thelioma has substantially added to the clinical importance of antifolates in ...
9
Applications of calixarenes in cancer chemotherapy: facts and perspectives
... and cancer tissues makes it difficult to specify the ...targeted chemotherapy, research on calixarenes loaded with anticancer drugs and their controlled release upon radiation will provide a new area of ...
8
Conditioned side effects of cancer chemotherapy
... It m ight be argued that, for a model of ANV, it is not im portant w hether or not the potentiation observed in the rat m odel is due to stimulus generalisation, since such generalisation m ay be expected to occur in the ...
170
The Mechanisms of Mitochondria-Mediated Apoptosis in Cancer Chemotherapy
... a cancer cell to its death, apoptotic cell death is a favored cell pathway, which unlike to necrosis does not lad to inflammation and leads to safe disposal of a dead cancer ...
5
Cisplatin-functionalized silica nanoparticles for cancer chemotherapy
... Cisplatin-functionalized silica particle breast cancer cell in- teractions were investigated by TEM analysis of thin sec- tioned cell samples. Representative micrographs are shown in Fig. 9, with images chosen ...
10
Recent Advances in Cancer Chemotherapy
... of cancer includes Lymphoma, Sarcoma, Lungs cancer, breast cancer, bladder cancer, cervical cancer, ovarian cancer, colorectal cancer ...etc. Cancer is not a single ...
16
Nedaplatin: a cisplatin derivative in cancer chemotherapy
... regimen is inconvenient because of the need for continuous administration over 5 days, and it sometimes causes renal dysfunction. To reduce the renal and gastrointestinal toxic- ity found with cisplatin, nedaplatin is ...
10
Recent Advances in Cancer Chemotherapy
... Since most chemotherapeutic drugs will kill cancer cells actively "in phase" in the cell cycle, it should follow that the smaller the tumor mass, the larger th[r] ...
8
Cancer chemotherapy: new strategies for success
... Another important strategy for the ultimate development of curative chemotherapy, which derives from the principle of first order kinetics in tumor cell kill, is the use of high dose sys[r] ...
6
Effectiveness of Antiemetics in the Management of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Following Chemotherapy Guidelines
... in cancer chemotherapy patients. A total of 2400 cancer patients were admitted to the hospital for their treatment during the study ...the chemotherapy regimen, 52 % (n=897) patients were in ...
9
THE ROLE OF CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER
... to Cancer Registry of the Republican Oncology scientific center (RONTS), in 2012 in the general structure ofcancer of malignant neoplasms of women forpatients with breast cancer ...common cancer in ...
5
Chemotherapy for Gastric Cancer “Who is an Asian Star?”
... Gastric cancer (GC) is major health problem worldwide, and the second leading cause of cancer- related death in ...to chemotherapy and tumor recurrence are major contributors to the poor prognosis of ...
6
Improving the chemotherapy process and service to cancer patients
... An intent to treat form was devised, and this form was tested using the Plan Do Study Act (PDSA) cycle. Initially, three consultants were involved in testing the feasibility of the introduced form. Gradually, the forms ...
5
Progress in adjuvant chemotherapy for breast cancer: an overview
... breast cancer in patients who had progressed after anthracycline-based combination chemotherapy or who relapsed less than 6 months after adjuvant therapy ...breast cancer showed greater efficacy for ...
13
Chemotherapy for non-small cell lung cancer
... This begins seven days after treatment and your resistance to infection is usually at its lowest 10–14 days after chemotherapy. The number of your white blood cells will then increase steadily and usually return ...
5
Adjuvant Chemotherapy and Interrelated Progression in Lung Cancer
... lung cancer com- munity, we must also advocate for our patients in order to ensure their access to the ongoing advances in the field and ultimately to better ...
9